Data-Driven Acquisition

Zach discusses the challenges of gathering sufficient data for pharmaceutical interest, highlighting the need for a larger sample size in oncology. To accelerate their data acquisition, he and his team decided to pursue the acquisition of an oncology electronic health record provider, believing it was a crucial step to prove their model at scale. They successfully pitched their funding strategy to two investors, securing the necessary capital to move forward with the acquisition.